Shoulder Innovations, Inc. (SI) Return on Equity (ROE): -33.14%
Is Shoulder Innovations, Inc.’s return on equity (ROE) high or low?
Shoulder Innovations, Inc.'s return on equity (ROE) of -33.14% is 30% above its 2-year average of -47.15%, near the high end of its 2-year range (-78.96%–-26.05%).
As of Sunday, June 21, 2026. 36.88% above its 12-month average of -52.50%.
SI Return on Equity (ROE) Chart
SI Average Return on Equity (ROE) Chart
SI Current vs Average Return on Equity (ROE) Chart
SI Return on Equity (ROE) Metrics
RETURN ON EQUITY (ROE)
-33.14%
RETURN ON EQUITY (ROE) AVG TTM
-52.50%
RETURN ON EQUITY (ROE) AVG 3Y
N/A
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+36.88%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SI Competitors' Return on Equity (ROE)
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $384.69M | -33.14% | -52.50% | N/A | N/A |
| 23andMe Holding Co. (ME)vs › | $15.31M | -721.75% | 348.35% | 157.32% | 61.09% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.07B | -47.65% | -45.75% | -30.11% | -18.95% |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 34.80% | 27.86% | 4.54% | -12.45% |
| Oscar Health, Inc. (OSCR)vs › | $7.36B | -2.37% | -21.41% | -36.14% | -25.75% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.64B | 2.46% | -8.94% | -15.72% | 1.14% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.91B | -2.97% | 25.09% | 5.57% | 0.40% |
| Tempus AI, Inc. (TEM)vs › | $8.87B | -72.74% | -651.33% | -315.37% | -198.08% |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.91B | -6.28% | -2.13% | 6.32% | 9.65% |
| Baxter International Inc. (BAX)vs › | $10.27B | -18.17% | -12.46% | -8.76% | -1.37% |
Return Analysis
ROE
-33.1%
ROA
-27.5%
Shoulder Innovations, Inc. Return on Equity (ROE) Formula & Definition
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Shoulder Innovations, Inc. Return on Equity (ROE) FAQ
- What is the return on equity (ROE) for Shoulder Innovations, Inc. (SI)?
- The return on equity (ROE) for SI stock is -33.14%.
- Is Shoulder Innovations, Inc.'s return on equity (ROE) high or low?
- Shoulder Innovations, Inc.'s return on equity (ROE) of -33.14% is 30% above its 2-year average of -47.15%, near the high end of its 2-year range (-78.96%–-26.05%).
- What is the TTM average return on equity (ROE) for Shoulder Innovations, Inc. (SI)?
- The TTM average return on equity (ROE) for SI stock is -52.50%.
Shoulder Innovations, Inc. Return on Equity (ROE) History
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | -26.05% |
| 2024-12-31 | -78.96% |
| 2023-12-31 | -36.43% |
Related Metrics
About Shoulder Innovations, Inc.
Shoulder Innovations, Inc. is a medical technology firm that engineers and produces sophisticated devices. The company is particularly recognized for designing an innovative shoulder replacement system. Co-founded in 2009 by Stephen B. Gunther and Michael DeVries, its main corporate office is situated in Grand Rapids, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Alan J. Lane